LDL quality is a novel, modifiable cardiovascular risk marker
LDL quality is a novel, modifiable cardiovascular risk marker.
Scientists at the Wihuri Research Institute and the University of Helsinki, Finland, developed a method that can be used to monitor the quality of circulating LDL particles by measuring the susceptibility of the LDL particles to aggregate.
The LDL aggregates have a tendency to accumulate in the arterial wall, where they induce the formation of cholesterol-rich plaques. LDL aggregates can also induce local inflammation in the plaques. An inflamed plaque can then rupture and cause myocardial infarction.
The scientists found that LDL isolated from patients with known cardiovascular disease was more aggregation-prone than LDL isolated from healthy individuals. The most aggregation-prone LDL was found in those patients who later died from cardiovascular disease.
“This is the first study to show that there are measurable inter-individual differences in the aggregation susceptibility of LDL particles, and that aggregation-prone LDL is predictive of cardiovascular death”, summarizes Dr. Katariina Öörni, who led the research team.
There is also good news: the study showed that the quality of LDL particles can be improved by cholesterol-lowering medication or by healthy diet. “Increase in consumption of vegetable oils and decrease in consumption of sugar decreased LDL aggregation”, describes Maija Ruuth, the first author of the research article.
In the future, the new measurement of LDL aggregation may help to improve cardiovascular risk. “This new biomarker may also facilitate identification of patients with currently unrecognized risk for cardiovascular events”, suggests Professor Petri Kovanen, a member of the research team.
The findings were published on July 4, 2018 in the European Heart Journal.
Materials provided by the University of Helsinki. Content may be edited for clarity, style, and length.